Global Neglected Tropical Diseases Drugs and Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Neglected Tropical Diseases Drugs and Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Neglected tropical diseases (NTDs) are a diverse group of tropical infections which are common in low-income populations in developing regions of Africa, Asia, and the Americas. They are caused by a variety of pathogens such as viruses, bacteria, protozoa and helminths.
Neglected Tropical Diseases Drugs and Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Neglected Tropical Diseases Drugs and Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Drugs and Vaccines are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Neglected Tropical Diseases Drugs and Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Neglected Tropical Diseases Drugs and Vaccine key companies include Artecef BV, GlaxoSmithKline, AstraZeneca, Novartis, Sanofi-Aventis, Ranbaxy Labs, Lupin, Macleods Pharmaceuticals and Cipla, etc. Artecef BV, GlaxoSmithKline, AstraZeneca are top 3 players and held % share in total in 2022.
Neglected Tropical Diseases Drugs and Vaccine can be divided into Malaria, Ebola, Dengue and Chagas, etc. Malaria is the mainstream product in the market, accounting for % share globally in 2022.
Neglected Tropical Diseases Drugs and Vaccine is widely used in various fields, such as Drugs and Vaccines, etc. Drugs provides greatest supports to the Neglected Tropical Diseases Drugs and Vaccine industry development. In 2022, global % share of Neglected Tropical Diseases Drugs and Vaccine went into Drugs filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Neglected Tropical Diseases Drugs and Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Artecef BV
GlaxoSmithKline
AstraZeneca
Novartis
Sanofi-Aventis
Ranbaxy Labs
Lupin
Macleods Pharmaceuticals
Cipla
Romark Laboratories
Toyama Chemica
Segment by Type
Malaria
Ebola
Dengue
Chagas
Leishmaniasis
Other
Drugs
Vaccines
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Neglected Tropical Diseases Drugs and Vaccine market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Neglected Tropical Diseases Drugs and Vaccine introduction, etc. Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Neglected Tropical Diseases Drugs and Vaccine market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Neglected Tropical Diseases Drugs and Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Neglected Tropical Diseases Drugs and Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Drugs and Vaccines are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Neglected Tropical Diseases Drugs and Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Neglected Tropical Diseases Drugs and Vaccine key companies include Artecef BV, GlaxoSmithKline, AstraZeneca, Novartis, Sanofi-Aventis, Ranbaxy Labs, Lupin, Macleods Pharmaceuticals and Cipla, etc. Artecef BV, GlaxoSmithKline, AstraZeneca are top 3 players and held % share in total in 2022.
Neglected Tropical Diseases Drugs and Vaccine can be divided into Malaria, Ebola, Dengue and Chagas, etc. Malaria is the mainstream product in the market, accounting for % share globally in 2022.
Neglected Tropical Diseases Drugs and Vaccine is widely used in various fields, such as Drugs and Vaccines, etc. Drugs provides greatest supports to the Neglected Tropical Diseases Drugs and Vaccine industry development. In 2022, global % share of Neglected Tropical Diseases Drugs and Vaccine went into Drugs filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Neglected Tropical Diseases Drugs and Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Artecef BV
GlaxoSmithKline
AstraZeneca
Novartis
Sanofi-Aventis
Ranbaxy Labs
Lupin
Macleods Pharmaceuticals
Cipla
Romark Laboratories
Toyama Chemica
Segment by Type
Malaria
Ebola
Dengue
Chagas
Leishmaniasis
Other
Segment by Application
Drugs
Vaccines
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Neglected Tropical Diseases Drugs and Vaccine market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Neglected Tropical Diseases Drugs and Vaccine introduction, etc. Neglected Tropical Diseases Drugs and Vaccine Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Neglected Tropical Diseases Drugs and Vaccine market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices